Literature DB >> 7313347

Lung compliance and alveolar expansion in the artificially ventilated premature newborn rabbit after maternal treatment with ambroxol.

B Lachmann, A B Tischer, G Grossmann, B Robertson.   

Abstract

Premature newborn rabbits were delivered on day 27 of gestation, with or without antenatal treatment with ambroxol (50 mg/kg/day in maternal injections, on days 24-26). The animals were tracheostomized, kept in body plethysmographs at 35 degrees C, and ventilated artificially for 10 min with 100% oxygen, insufflation pressure 30 cm H2O, frequency 40/min, and varying inspiration time (20, 40, 60, or 80%). Lung-thorax compliance increased with inspiration time in both ambroxol-treated animals and controls, but there was no difference in compliance between treated and non-treated litters. Alveolar expansion, evaluated morphometrically in histological sections, was enhanced in ambroxol-treated animals ventilated with prolonged inspiration phase (60 or 80%); such a difference was not found in the on-treated group. This suggests that antenatal treatment with ambroxol might have a stimulating effect on the synthesis and/or release of factors improving alveolar stability in the premature lung.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7313347     DOI: 10.1159/000194430

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  1 in total

1.  Ambroxol - Resurgence of an old molecule as an anti-inflammatory agent in chronic obstructive airway diseases.

Authors:  P R Gupta
Journal:  Lung India       Date:  2010-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.